GC15344
SP 600125
Also known as 14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one
SP 600125 is an orally active, reversible, selective, ATP-competitive JNK inhibitor with IC50 of 40, 40, and 90 nM for JNK1, JNK2, and JNK3, respectively· SP 600125 is commonly used in the research of ovarian cancer, tumors, Parkinson's disease (PD), breast cancer, and asthma
ChemicalCAS129-56-6MW220.23FormulaC14H8N2O
- CAS number
- 129-56-6
- Molecular weight
- 220.23
- Formula
- C14H8N2O
- Solubility
- ≥ 11mg/mL in DMSO, ≥ 2·56 mg/mL in EtOH with gentle warming
- InChIKey
- ACPOUJIDANTYHO-UHFFFAOYSA-N
- Catalogue number
- GC15344
- Brand
- GLPBIO
Computed properties PubChem CID 8515 · XLogP 2.7 · TPSA 45.8 Ų · H-bond donors 1
- XLogP
- 2.7
- TPSA
- 45.8 Ų
- H-bond donors
- 1
- H-bond acceptors
- 2
- Rotatable bonds
- 0
- Heavy atoms
- 17
SMILES C1=CC=C2C(=C1)C3=NNC4=CC=CC(=C43)C2=O
Computed descriptors from PubChem (CID 8515), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il